|
FY2026
12 months to May 31, 2026
|
FY2025
12 months to May 31, 2025
|
FY2024
12 months to May 31, 2024
|
FY2023
12 months to May 31, 2023
|
FY2022
12 months to May 31, 2022
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash flows from operating activities | |||||
| Depreciation | |||||
| Amortization | |||||
| Stock options issued for services | |||||
| Credit loss expense (recovery) | |||||
| Loss on disposal of property and equipment | |||||
| Provision for inventory obsolescence | |||||
| Deferred income taxes | |||||
| Changes in other assets and liabilities | |||||
| Accounts receivable, net | |||||
| Inventory | |||||
| Prepaid expenses | |||||
| Prepaid income taxes | |||||
| Costs and estimated earnings in excess of billings | |||||
| Accounts payable | |||||
| Accrued expenses | |||||
| Billings in excess of costs and estimated earnings | |||||
| Accrued income taxes | |||||
| Other assets | |||||
| Net operating activities | |||||
| Investing activities | |||||
| Acquisition of property and equipment | |||||
| Patent expenditures | |||||
| Increase in short-term investments | |||||
| Increase in cash value of life insurance | |||||
| Net investing activities | |||||
| Financing activities | |||||
| Proceeds from issuance of common stock | |||||
| Acquisition of treasury stock | |||||
| Net financing activities | |||||
| Net change in cash and cash equivalents | |||||
| Cash and cash equivalents - beginning | |||||
| Cash and cash equivalents - ending | |||||
Loading...